Radiopharmaceuticals for targeted radiotherapy of cancer

This publication has 22 references indexed in Scilit:

• Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter
  Nuclear Medicine and Biology, 1998
• In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma
  American Journal of Obstetrics and Gynecology, 1997
• Efficient production of high specific activity 64Cu using a biomedical cyclotron
  Nuclear Medicine and Biology, 1997
• Targeted therapy using alpha emitters
  Physics in Medicine & Biology, 1996
• (2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice
  Nuclear Medicine and Biology, 1994
• Stable anionic, neutral and cationic complexes of gadolinium with functionalised amino-phosphinic acid macrocyclic ligands
  Journal of the Chemical Society, Chemical Communications, 1992
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Somatostatin
  New England Journal of Medicine, 1983
• Radioactive Labeling of Antibody: A Simple and Efficient Method
  Science, 1983
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982